newsfilter
← Latest News
GlobeNewswire·

Design Therapeutics to Participate in the 2022 Wedbush PacGrow Virtual Healthcare Conference

CARLSBAD, Calif., Aug. 03, 2022 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (NASDAQ:DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic diseases, today announced that João Siffert, M.D., president and